Lannett Company (LCI)

This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below.

From 1

Company Information:

Company Address:

9000 State Road

Philadelphia, PA 19136

Company’s Web Address: http://www.lannett.com/

Industry Sector:

Fiscal Year:

Dividend:


Note: this section is not editable. Please click here to report any inaccuracies.
Shares Outstanding: 24,200,000
Market Capitalization: Updating...

Income Statements
Click for: Annual Income Statement
Click for: Quarterly Income Statement

Balance Sheets
Click for: Annual Balance Sheet
Click for: Quarterly Balance Sheet

Cash Flow Statements
Click for: Annual Cash Flow Statement
Click for: Quarterly Cash Flow Statement

SEC Filings
Click for: Form 10-Ks
Click for: Form 10-Qs
Click for: Annual Proxy Statements
Link to SEC filings search: http://www.sec.gov/cgi-bin/srch-edgar

Company Overview:

Company Products/Services/Markets:

Enter Company Products/Services Here

Strategy:

Describe Key Aspects of Company's Strategy Here

Competitors:

Enter Competitors Here

Industry Trends and News:

Enter Industry Trends and News Here

Acquisitions, Divestitures, Major Transactions, Spin-offs :

Enter Acquisitions, Divestiures, Major Transactions, Spin-offs Here

Management – Pros & Cons, Changes:

Enter Management - Pros & Cons, Changes Here

Financial Analysis:

Enter Financial Analysis Here

Valuation:

Enter Valuation Analysis and Valuation Ratios Here

  2007 2006 2005
Price/Earnings


Price/EBITDA


Price/Pre-tax Income


Price/Revenue


Investment Rationale:

Buy Rationale:

Enter Buy Rationale Here

Sell Rationale:

Enter Sell Rationale Here

Projected Financials:

Income Statement: (Paste Here)

Balance Sheet: (Paste Here)

Cash Flow Statement: (Paste Here)

Financial Ratios: (Paste Here)

Other: (Paste Here)

Discussion:

This area is for debates regarding different recommendations for this stock.

Footnotes:

News:

Yahoo! Finance: LCI News
Lannett challenging KV's Ther-Rx patent rights (at bizjournals.com)
KV unit sued by Lannett in patent challenge (AP)
KV Pharmaceutical Co. said Tuesday a subsidiary's patent on the prenatal vitamin product PrimaCare One is being challenged by generic drug developer Lannett Co.
LANNETT CO INC Financials (EDGAR Online Financials)
Lannett Company to Launch Amantadine Hydrochloride Soft Gel Capsules, 100 mg (Business Wire)
PHILADELPHIA----Lannett Company, Inc. , a manufacturer of generic pharmaceuticals, today said that it expects to commence marketing Amantadine Hydrochloride Soft Gel Capsules 100mg, within the next several months.
New Star Analyst Rankings for LANNETT COMPANY INC (StarMine)
Lannett Reports Fiscal 2008 Third-Quarter Financial Results (Business Wire)
PHILADELPHIA----Lannett Company, Inc. today reported financial results for the fiscal 2008 third quarter and nine months ended March 31, 2008.
LANNETT CO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Lannett Company Provides Update on Marketing Digoxin Tablets (Business Wire)
PHILADELPHIA----Lannett Company, Inc. , a manufacturer of generic pharmaceuticals, said today that it continues to work closely with the U.S. Food and Drug Administration to ensure that an uninterrupted and safe supply of Digoxin Tablets is available for U.S. patients, following the FDA's announced recall of Digitek® brand of Digoxin.
LANNETT CO INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Lannett stockholder sells shares to sons' company (at bizjournals.com)
Lannett Chairman Transfers Five Million Shares of Stock (Business Wire)
PHILADELPHIA----Lannett Company, Inc. announced today its chairman, William Farber, has sold five million shares of Lannett Company common stock to Farber Properties Group, LLC, a Limited Liability company owned and controlled by two of Farber's sons.
Lannett Company to Remain a Major Marketer of Digoxin Tablets (Business Wire)
PHILADELPHIA----Lannett Company, Inc. today said it will continue to market its Digoxin Tablets and that the company's Digoxin product is not subject to the recent FDA announced recall of Digitek®, the brand version of Digoxin Tablets.
LANNETT CO INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Stateme (EDGAR Online)
LANNETT CO INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
LANNETT CO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Wednesday's Health Winners & Losers (at TheStreet.com)
LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)
LANNETT CO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
LANNETT CO INC Files SEC form 10-Q/A, Quarterly Report (EDGAR Online)
LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)

See Also (links to blogs, forums, external sources, etc...):

Tags:
none
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
 
Images (0)
 
Comments (0)
You must login to post a comment.